Saturday, October 17, 2026
Home Brand Positioning Page 15

Brand Positioning

Most popular
Pharmaceutical executives presenting clinical data during a high-profile FDA advisory committee meeting with media and healthcare stakeholders present.

Advisory Committees as Brand Moments: Preparing for Public Scientific Scrutiny

Donna Pacheco -
0
Pharmaceutical market access professionals reviewing health technology assessment data, reimbursement models, and value-based pricing strategies during a strategic planning meeting.

The New Pricing Gatekeeper: Why HTA Is Becoming Pharma’s Biggest Marketing...

Donna Pacheco -
0
Pharmaceutical communications team monitoring market sentiment and FDA advisory vote outcomes during a critical 48-hour response window.

The 48-Hour Window: What Happens After an FDA Advisory Vote Can...

Donna Pacheco -
0
pharma-ai-bias-audit-clinical-fairness

The AI-Bias Audit: Why Pharma Marketers Must Champion Clinical Fairness

Donna Pacheco -
0
Doctor facing prior authorization barriers and prescribing friction inside an electronic health record system

The Frictionless Script: Why “Covered” Drugs Still Fail at the Point...

Donna Pacheco -
0

Designing Consent: How Better UX Builds Patient Trust in Pharma

Donna Pacheco -
0
GLP-1 injection pen, medication vial, and safety warning materials illustrating overdose concerns, dosing errors, and pharmaceutical risk communication challenges.

The GLP-1 Safety Reckoning: Why Overdose Headlines Are Becoming a Marketing...

Donna Pacheco -
0
Global pharmaceutical supply chain network showing medicine distribution, secure manufacturing operations, logistics infrastructure, and reliable drug delivery systems.

Drug Shortages Changed the Rules: When Reliability Becomes a Marketing Advantage

Donna Pacheco -
0
Pharmaceutical compliance concept with balance scale, pills, and caution tape symbolizing risk and regulation in marketing strategy

The Compliance Paradox: When Playing It Safe Becomes the Biggest Risk

Donna Pacheco -
0
Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

Donna Pacheco -
0
1...141516...24Page 15 of 24
- Advertisement -

EDITOR PICKS

POPULAR POSTS

RECENT POSTS

POPULAR CATEGORY

© 2026. Pharma Marketing Network. All rights reserved.